Bing

SEARCH HISTORY

Amgen shares (AMGN.O) led the S&P 500's decline ... Healthcare companies have been the top performers so far in 2015, helping push major stock indexes to records. Biotechs in particular have driven up the Nasdaq, which last week reached its first all ...
Reuters · ByCaroline Valetkevitch · 4/27/2015
A month ago, Amgen ($AMGN) and AstraZeneca ($AZN) were confidently rolling up data from three highly touted late-stage studies on the psoriasis drug brodalumab for a new ... while AstraZeneca's stock was down 1.6%. Suicidal thoughts, along with …
Fierce Biotech · ByJohn Carroll · 5/23/2015
In a year when several of his peers won big payoffs for one extraordinary reason or another, Amgen ($AMGN) CEO Robert Bradway earned just ... relocation expenses and stock awards worth almost $7 million.
FiercePharma · ByTracy Staton · 4/6/2015
SocialFunds.com -- Social investors will no longer have to go wanting for a benchmark of the tech-heavy Nasdaq stock market. KLD Research & Analytics ... which has notably strong diversity policies; Amgen, Inc. (AMGN), a biotech research and production ...
Social Funds · 2/12/2002
Levkovich analyzed the fifty largest actively-managed mutual funds, and looked at the top ten stock holdings of each fund. Levkovich then tallied the number of times a single stock appeared in a fund's top ten holdings, and ranked the companies accordingly.
The Business Insider · 6/9/2015
When a breakout stalls, it doesn't feel good. But feelings can be a poor guide in the stock market. What factors should you consider when trying to sit through a breakout that wobbles? Some stocks edge slowly higher, either in heavy or light turnover ...
Investor's Business Daily · 3/24/2015
Gilead Sciences Inc. (NASDAQ:GILD) [Detail Analytic Report] stock shows 50% growth in its price over the last year. Gilead has become one of the leading growing companies in the BioPharma industry in the country. Gilead has been on the oath of growth …
streetwisereport.com · 6/25/2015
The Bottom Line. In the wake of the Amgen (AMGN) bid to buy biotech Micromet (MITI), investors and traders with an appetite for risk might want to consider CytRx Corporation (CYTR) and Sunesis Pharmaceuticals (SNSS) as potential acquisition bets …
Smallcap Network · ByJohn Udovich · 3/22/2012
Shifts in the outlook for interest rates are causing stock prices to be far more volatile than long-run fundamentals. Following a comprehensive review of competitive dynamics in the global banking industry, we upgraded our moat ratings for eight banks to wide.
news.morningstar.com · 6/29/2015
A federal judge rejected Amgen Inc.'s effort to temporarily block a competitor from releasing a copycat version of one of its top-selling biologic drugs. The Thousand Oaks biotech company had accused Novartis subsidiary Sandoz of violating the law in its ...
Los Angeles Times · ByStuart Pfeifer · 3/19/2015

Amgen

Company
Amgen is an American multinational biopharmaceutical company headquartered in Thousand Oaks, California. Locate…
Amgen is an American multinational biopharmaceutical company headquartered in Thousand Oaks, California. Located in the Conejo Valley, Amgen is the world's largest independent biotechnology firm. In 2013, the company's largest selling product lines were Neulasta/Neupogen, two closely related drugs used to prevent infections in patients undergoing cancer chemotherapy; and Enbrel, a tumor necrosis factor blocker used in the treatment of rheumatoid arthritis and other autoimmune diseases. Other products include Epogen, Aranesp, Sensipar/Mimpara, Nplate, Vectibix, Prolia and XGEVA.
Data from: Wikipedia